092730 — NeoPharm Share News
0.000.00%
- KR₩364bn
- KR₩221bn
- KR₩132bn
Brief: Neopharm Q1 Operating Profit 7.8 Billion Won, Up 14.6% From Year Earlier
Brief: Neopharm Q4 Operating Profit 6.7 Billion Won, Down 3.8% From Year Earlier
Brief: Neopharm Q2 Operating Profit 6.1 Billion Won, Down 2.7% From Year Earlier
Brief: Neopharm Q1 Operating Profit 7 Billion Won, Down 3.5% From Year Earlier
Brief: Neopharm Q4 Operating Profit 7 Billion Won, Up 15.4% From Year Earlier
Brief: Neopharm Q3 Operating Profit 5 Billion Won, Up 22% From Year Earlier
Brief: Neopharm Q2 Operating Profit 6.3 Billion Won, Up 27% From Year Earlier
Brief: Neopharm receives patent
Brief: Neopharm to pay annual cash dividend as 500 won/share for 2017
Brief: Neopharm to pay annual dividend as 350 won/share for FY 2016
Brief: Neopharm changes CEO to Lee Dae Yeol